Download DNB 2019 June RADIOTHERAPY RADIOTHERAPY PAPER 3 Question Paper

FirstRanker.com
Firstranker's choice

FINAL EXAM

--- Content provided by FirstRanker.com ---

--- Content provided by‌ FirstRanker.com ---

Important Instructions:

1. Attempt all questions in order.
2. Each question carries 10 marks.
3. Read the question carefully and answer to the point neatly and legibly.
4. Do not leave any blank pages between two answers.

--- Content provided by FirstRanker.com ---

5. Indicate the question number correctly for the answer in the margin space.
6. Answer all the parts of a single question together.
7. Start the answer to a question on a fresh page or leave adequate space between two answers.
8. Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

--- Content provided by FirstRanker.com ---

1. a) GIST (5+5)
   b) Paraneoplastic syndromes
2. a) Briefly describe the changes in the treatment philosophy of rectal cancers. (5+5)
   b) Targeted therapy in stage IV cancer colon.
3. a) Chordoma (5+5)
   

   --- Content provided by FirstRanker.com ---

   b) Craniopharyngioma
4. a) Management of GBM in patient more than 65 years of age. (4+3+3)
   b) Correlation between MGMT methylation and use of temozolamide.
   c) Recursive partitioning analysis in management of malignant brain tumours.
5. a) Describe different types of malignant melanoma. (3+2+5)
   

   --- Content provided by‍ FirstRanker.com ---

   b) In-transit metastasis.
   c) Systemic therapy in stage IV melanoma.
6. a) Clinical, radiological and histological features of Ewing’s sarcoma. (6+4)
   b) Schematic flow chart for management of Ewing’s sarcoma.
7. a) CSI - Craniospinal irradiation techniques & indications. (5+5)
   

   --- Content provided by FirstRanker.com ---

   b) PCI — Prophylactic cranial irradiation techniques & indications.
8. a) Outline the management strategy of febrile neutropenia. (5+5)
   b) Etiopathology and management of osteoradionecrosis.
9. a) Imatinib (4+3+3)
   b) Denosumab
   

   --- Content provided by⁠ FirstRanker.com ---

   c) Sorafenib
10. a) Radio-immunotherapy. (5+5)
    b) Boron-neutron capture therapy.

FirstRanker.com

POSSESSION/USE OF CELL PHONES OR ANY ELECTRONIC GADGET IS NOT PERMITTED INSIDE THE EXAMINATION HALL.

--- Content provided by‌ FirstRanker.com ---